LEGEND BIOTECH CORP-ADR (LEGN) Stock Income Statement
NASDAQ:LEGN - Nasdaq - US52490G1022 - ADR - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 728.30M | 627.24M | 285.14M | 117.00M | 68.80M | |||
| Cost Of Goods | 251.19M | 234.58M | 144.21M | 65.40M | N/A | |||
| Gross Profit | 477.12M | 392.66M | 140.93M | 51.60M | N/A | |||
| Operating Expenses | 715.05M | 697.81M | 668.89M | 509.70M | 462.80M | |||
| Research and Development | 414.50M | 413.54M | 382.22M | 335.60M | 313.30M | |||
| Selling, General, and Administrative Expenses | 300.54M | 284.26M | 200.93M | 174.00M | 149.50M | |||
| Operating Income | -237.93M | -305.15M | -527.97M | -458.10M | -394.00M | |||
| Interest Income/Expense | -34.25M | 39.59M | 33.36M | 18.30M | -6.10M | |||
| Other Income/Expense | 80.10M | 111.85M | -25.51M | -6.00M | -7.00M | |||
| Non Recurring Items | N/A | -4.42M | N/A | N/A | N/A | |||
| Income Before Taxes | -197.47M | -158.13M | -520.12M | -445.70M | -407.20M | |||
| Income Tax | 20.67M | 18.89M | -1.86M | 600.00K | -3.60M | |||
| Net Income | -218.15M | -177.03M | -518.25M | -446.30M | -403.60M | |||
| EBITDA | -215.09M | -281.79M | -507.51M | -439.70M | -380.10M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.19 | -0.97 | -2.95 | -2.80 | -2.86 | |||
| Non GAAP EPS | -1.17 | -0.95 | -2.96 | N/A | -1.35 | |||
| Statistics | ||||||||
| Gross Profit Margin | 65.51% | 62.60% | 49.42% | 44.10% | N/A | |||
| Profit Margin | -29.95% | -28.22% | -181.75% | -381.45% | -586.63% | |||
| Operating Profit Margin | -32.67% | -48.65% | -185.16% | -391.54% | -572.67% | |||
All data in USD